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Effect of chronic dissection on early and late
outcomes after descending thoracic and
thoracoabdominal aneurysm repair
Mark F. Conrad, MD, MMSc,a Thomas K. Chung, MS,a Matthew R. Cambria, BS,a
Vikram Paruchuri, MD,a Thomas J. Brady, MD,b and Richard P. Cambria, MD,a Boston, Mass
Objective: Although chronic aortic dissection (CD) has traditionally been considered a predictor of perioperative
morbidity and mortality after descending thoracic/thoracoabdominal aneurysm repair (thoracoabdominal aortic aneu-
rysm [TAA]), recent reports have rejected this assertion. Still, few contemporary studies document late outcomes after
TAA for CD, which is the goal of this study.
Methods: From August 1987 to December 2005, 480 patients underwent TAA; 73 (15%) CD and 407 (85%) degenerative
aneurysms (DA). Operative management consisted of a clamp-and-sew technique with adjuncts in 53 (78%) CD and 355
(93%) DA patients (P < .001). Epidural cooling was used to prevent spinal cord injury (SCI) in 51 (70%) CD and 214
(53%) DA patients (P .007). Study end points included perioperative SCI/mortality, freedom from reintervention, and
long-term survival.
Results:CD patients were younger (mean age 64.5 years CD vs 72.5 years DA, P< .001) and more frequently had a family
history of aneurysmal disease (23% CD vs 6% DA, P < .001). Forty-three (59%) CD patients had elective TAA (vs 322
(79%) DA, P .001). Eleven (15%) CD patients had Marfan’s syndrome (vs 0% DA, P< .001), and 17 (23%) CD patients
had a prior arch or ascending aortic repair (vs 16 [4%] DA, P< .001). CD patients were more likely to have Crawford type
I & II thoracoabdominal aneurysms (44 [60%] vs 120 [29%] DA, P < .001), while only two (3%) CD patients had type
IV aneurysms (vs 99 [24%] DA). There was no difference in perioperative mortality between the two groups (11% CD vs
8.6% DA, P .52), nor was there a difference in flaccid paralysis, which occurred in five (7%) CD and 22 (5%) DA patients
(P .92). At 5 years, 70% of CD patients were free from reintervention versus 74% of DA (P .36). The actuarial survival
was 53% and 32% at 5 and 10 years for CD versus 47% and 17% for DA (P  .07).
Conclusions: Despite increased operative complexity, CD does not appear to increase perioperative SCI or mortality after
TAA when compared with DA. Long-term freedom from aneurysm-related reintervention is similar for both groups as
is survival, despite patients with CD being of younger age at presentation. (J Vasc Surg 2011;53:600-7.)
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tPatients with chronic type B aortic dissections (CD) are
at risk of aneurysmal dilation of the outer wall of the false
lumen, with an unpredictable temporal sequence.1 It has
been estimated that over 50% of patients with CD will
rupture or require thoracoabdominal aortic aneurysm
(TAA) resection within 4 years of their initial presenta-
tion.2-4 These patients typically require a more complex
operative repair than patients with degenerative aneurysms
(DA), which can lead to longer cross-clamp durations and
increased renal and spinal cord ischemia. Indeed, in Craw-
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600ord’s sentinel report of 605 patients, CD was associated
ith a significantly higher risk of paraplegia than patients
ith degenerative aneurysms (30.4% vs 7.4%, P .0001),5
nd a subsequent review of the world’s literature 10 years
ater also identified CD as a predictor of increased spinal
ord ischemic (SCI) risk.3 This in turn has often been
elated to maintenance of intercostal vessel patency in
neurysms of chronic dissection versus degenerative etiol-
gy.6
The addition of intra-procedural adjuncts such as distal
ortic perfusion via atrial-femoral bypass,7,8 epidural cool-
ng (EC),9 and the monitoring of motor evoked poten-
ials10 has improved the expected paraplegia rates after
epair of types I–III TAA. In several recent series that have
pplied these adjuncts to TAA repair, dissection was no
onger identified as a predictor of adverse outcomes on
ultivariate analysis.11,12 However, little has been docu-
ented regarding the late outcomes of TAA repair in
atients with CD. The goal of this study is to compare the
esults of TAA repair between patients with CD and DA in
contemporary series with long-term follow-up.
ETHODS
Clinical, demographic, and operative details of all pa-
ients undergoing TAA repair at our institution have been
rospectively collected and maintained in a database
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Volume 53, Number 3 Conrad et al 601throughout the study interval (August 1, 1987-December
30, 2005). A review of this database identified 480 patients
who underwent open descending thoracic or thoracoab-
dominal aneurysm repair during the study period, which
included those who underwent both elective and emergent
repair. The distribution of procedures is as follows: 52
(11%) descending thoracic, 82 (17%) type I TAA, 82 (17%)
type II TAA, 163 (34%) type III TAA, and 101 (21%) type
IV TAA. Patients were stratified into two cohorts based on
the underlying cause of the aneurysm (CD vs DA). The 73
(15%) patients who presented with chronic dissection com-
prise the study cohort. The Institutional Review Board of
the Massachusetts General Hospital approved this proto-
col, and individual consent was waived.
Pre- and intraoperative variables as well as perioperative
outcomes were prospectively compiled over the study pe-
riod. Chronic obstructive pulmonary disease (COPD) was
determined by preoperative pulmonary function tests that
were obtained on most patients. Urgent operation was
defined as either rupture or presentation with acute aortic
syndrome necessitating invasive monitoring in an intensive
care unit and operative repair within 48 hours of admission.
Renal insufficiency was defined as a creatinine1.8 mg/dl,
and patients were considered to have a history of heart
disease even if they had previously been revascularized with
coronary artery angioplasty or bypass grafting.
Operative conduct
The clamp and sew technique with or without neuro-
protective adjuncts was used in 90% of cases. Distal aortic
perfusion was reserved for patients with anticipated techni-
cally complex proximal anastomosis or significant renal
insufficiency and was used in approximately 10% of the
procedures. EC has been used for spinal cord protection at
our institution since July of 1993 (types I–III TAA) and
when implemented, was supervised in all cases by a dedi-
cated vascular anesthesia team. Details of the clamp and sew
technique and the epidural infusion system have been pre-
viously reported.13,14 In brief, the EC system uses an iced
saline epidural infusion, which provides for moderate (25-
27°C) hypothermia to the spinal cord during the critical
period when the aorta is cross-clamped. Patent intercostals
vessels in the T9-L1 region were reimplanted by means of a
separate inclusion button or were preserved with a beveled
anastomosis when technically feasible. Following reperfu-
sion of the lower extremities, EC was discontinued and
continuous passive cerebrospinal fluid (CSF) drainage (to
keep CSF pressure at 10 mm Hg) was initiated and contin-
ued for 48 hours.
Clinical end points
The primary end points of this study included periop-
erative paraplegia and mortality, long-term freedom from
aneurysm-related reintervention, and survival. Periopera-
tive mortality was defined as any death within 30 days of the
procedure or any death occurring during the initial hospi-
talization. All patients were awakened in the operating
room for a postoperative baseline neurological examination af the lower extremities. SCI were classified as immediate
hen noted as the patient awoke from anesthesia, or as
elayed when they developed in a patient who was initially
eurologically intact. All patients who were expected to
ave a neurologic deficit postoperatively underwent clinical
valuation by a neurologist. Severity of spinal cord deficit
as stratified according to the spinal cord ischemia deficit
SCID) scoring system as previously described.15 The cat-
gories can be summarized as:
CID I: Flaccid paralysis.
CID II: Average neurologic muscle grade indicates50%
function.
CID III: Average neurologic muscle grade indicates
50% function.
Aneurysm-related reintervention included any proce-
ure performed within the initial hospital stay (including
e-exploration for bleeding, tracheostomy, additional aor-
ic procedures, etc) and any aortic-related procedures dur-
ng long-term follow-up. Major pulmonary complications
ncluded mechanical ventilation for more than 72 hours
ostoperatively, reintubation, respiratory failure requiring
ntensive care unit monitoring, pneumonia, or need for
racheostomy. Significant renal failure included postopera-
ive creatinine levels 3.0 mg/dl in patients with normal
aseline levels or need for dialysis. Cardiac complications
ncluded myocardial infarction as confirmed by electrocar-
iogram and appropriate laboratory values or any cardiac
vent that required intervention. The majority of gastroin-
estinal complications involved bleeding episodes, and
trokes were confirmed using appropriate imaging tech-
iques. Early and long-term freedom from reintervention
nd survival were determined by a review of office charts
nd the hospital’s computerized medical record. Patients
ho were last known to be alive but had not been seen in
ver a year were queried in the Social Security Death Index
SSDI) database to ensure an accurate account of current
urvival status, while patients who had not been seen for 5
ears and had no record in the SSDI were considered lost to
ollow-up.
Statistical analysis was performed using Chi-square or
isher’s exact test as appropriate for nominal variables. The
tudent t and Wilcoxon tests were used to assess continu-
us variables. Long-term mortality was determined using
aplan-Meier survival methods. A Cox proportional hazard
odel was used to determine multivariate predictors of
ong-term survival. A P value of .05 was considered
ignificant.
ESULTS
There were 480 patients who underwent open TAA
epair during the study interval, of whom 73 (15%) had
neurysms of CD etiology, and 407 (85%) were due to DA.
he clinical and demographic features of the cohort strati-
ed by indication are detailed in Table I. Patients with CD
ere younger, more likely to be male, and have a priorscending aneurysm repair than patients with DA. The
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March 2011602 Conrad et aldistribution of aneurysm extent was different between the
two groups (P  .001) and is detailed in Table II.
Patients with CD were more likely to be symptomatic
upon presentation than those with DA (CD: 47 [65%], DA:
132 [35%], P  .001), and elective repair was more com-
mon in patients with DA (CD: 43 [59%], DA: 322 [79%],
P  .001). In addition, patients with CD were more likely
to present with rupture than those with DA (CD: 16 [22%],
DA: 43 [11%], P  .001). The clamp and sew technique
was used in 53 (78%) patients with CD versus 355 (93%)
patients with DA (P .001), and there was no difference in
the use of EC between the two groups when type IV TAA
was excluded (CD: 51 [72%], DA: 195 [64%], P  .20).
The total aortic cross clamp time was similar for both
groups (CD: 81 29 minutes, DA: 75 27 minutes, P
.21), but the total operative time was longer for the CD
group (CD: 366  116 minutes, DA: 306  91 minutes,
P  .001). Total transfusion requirement (both banked
blood and cell saver transfusion) was also significantly
higher in the CD group (3.97 L 2.2 L, DA: 1.3 L .84
L, P  .001).
Mortality occurred in the perioperative period in eight
Table I. Demographic and clinical data for 480 patients
undergoing open TA/TAA repair stratified by indication
Variable
Chronic
dissection Degenerative P value
# patients (%) 73 (15) 407 (85)
Age, mean  SD years 64.5  13.5 72.5  8.4 .001
Male gender (%) 47 (64) 188 (46) .004
CAD (%) 28 (38) 197 (48) .11
Smoker (%) 54 (74) 336 (83) .08
Diabetes (%) 5 (7) 29 (7) 1.00
Hypertension (%) 67 (92) 354 (87) .25
Family history (%) 17 (23) 26 (6) .001
Serum creatinine 1.8 (%) 7 (10) 60 (15) .24
Prior AAA (%) 15 (21) 91 (22) .73
Prior ascending aneurysm
(%)
17 (23) 16 (4) .001
Marfan’s syndrome (%) 11 (15) 0 .001
AAA, Abdominal aortic aneurysm; CAD, coronary artery disease; TA,
thoracic aneurysm; TAA, thoracoabdominal aortic aneurysm.
Table II. Aneurysm extent stratified by indication for
open repair
Extent
Chronic
dissection Degenerative P value
# patients (%) 73 (15) 407 (85)
Descending thoracic
aneurysm (%)
14 (19) 38 (9) .001
Crawford type I (%) 22 (30) 60 (15)
Crawford type II (%) 22 (30) 60 (15)
Crawford type III (%) 13 (18) 150 (37)
Crawford type IV (%) 2 (3) 99 (24)
The P value is balanced across all extents of aneurysm repair and not specific
to one individual type.(11%) patients with CD and 35 (8.5%) patients with DA pP .52), and there was no difference in SCI (any degree of
ny deficit) between the two groups (CD: 12 [16%], DA:
5 [11%], P  .19). When only elective cases were consid-
red, the perioperative mortality was 7% for both groups
P .97). Immediate SCI occurred in seven (10%) patients
ith CD and 26 (6%) patients with DA (P .32), and there
as no difference in SCID classification which is detailed in
able III. Half (6/12) of the SCI in the CD group oc-
urred in type II TAA, while only 25% (11/45) of the DA
ere type II TAA. There were two (4%) cases of SCI in type
V TAA in the DA cohort. Intercostal artery reimplantation
as a separate inclusion button) was performed in 54% (65%
f patients with Type I and II repairs) of all cases but was
ore common in patients with CD (CD: 67% vs DA: 52%,
 .02). Intercostal artery reimplantation was not protec-
ive from SCI in this series, as the SCI rate was 11.7% in
atients who had intercostals reimplanted and 12.7%
n those who did not (P .74). There was no difference in
ther complications which are summarized in Table III.
The average follow-up was 48 months (range, 0-208
onths) for the total cohort (CD  53 months [range,
-208 months] vs DA  46 months [range, 0-204
onths], P  .26). There was no difference in freedom
rom aneurysm-related reintervention between the two
roups; P  .36 (Fig 1). There was also no difference in
urvival, which was 53% and 32% at 5 and 10 years for the
D group and 47% and 17% for DA at the same time
oints; P .07 (Fig 2). Multivariate predictors of death are
ummarized in Table IV.
ISCUSSION
This series showed that patients who undergo TAA for
D have a higher preoperative risk profile than those with
A, as they were more likely to present in an emergent/
rgent fashion, to have a connective tissue disorder, and to
e Crawford types I and II TAA. It has been abundantly
ocumented that extent I and II lesions have a higher risk
f SCI, and we and others have documented increased
able III. Details of spinal cord ischemia and other
omplications stratified by indication for repair
ariable
Chronic
dissection
(n  73)
Degenerative
(n  407)
P
value
pinal cord ischemia 12 (16.4%) 45 (11.1%) .19
mmediate SCI 7/12 (58%) 26/45 (57%) .97
CID I (flaccid) 5/12 (42%) 22/45 (49%) .88
CID II 4/12 (33%) 12/45 (27%)
CID III 3/12 (25%) 11/45 (24%)
ardiac complications 10/73 (14%) 64/407 (16%) .66
troke 2/73 (3%) 22/407 (5%) .34
ulmonary
complications
36/73 (49%) 192/407 (47%) .74
I complications 5/73 (7%) 44/407 (11%) .30
enal failure 8/73 (11%) 44/407 (11%) .97
I, Gastrointestinal; SCI, spinal cord ischemia; SCID, spinal cord ischemia
eficit score.erioperative risks (including increased SCI and mortality)
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Volume 53, Number 3 Conrad et al 603for nonelective operations.5,9,16-20 However, there was no
difference in the 30-day mortality or paraplegia rates be-
tween CD and DA in this series. Long-term surveillance
showed no difference in freedom from aneurysm-related
reintervention, and there was no difference in survival
between the two groups with several patients living 15
years. Negative predictors of long-term survival did include
increasing age, spinal cord ischemia, preoperative creati-
nine, and pulmonary function; age was the only variable
that differed between the CD and DA cohorts.
The association between CD and perioperative spinal
cord ischemia after TAA has evolved over the last 20 years.
Crawford’s early results with 605 patients (without the use
of adjuncts) showed CD to be a significant predictor of
spinal cord ischemia on multivariate analysis.5 However,
when Svensson presented the extension of this series to
1509 patients (now with the selective use of adjuncts),
chronic dissection was only significant on univariate analy-
sis and was eliminated from the multivariate model.8 A
study from the Cleveland Clinic of patients treated during
the same time period as Crawford’s original series reported
a paraplegia rate of 35% in the 16 patients with dissection.
This was not significantly different from the overall 21%
incidence of paraplegia in the series but likely would have
been if the study was powered adequately.21 Safi et al
Fig 1. Kaplan-Meier estimate for freedom from aneury
fied by indications (CD vs DA).
Years 0 1 2 3
At risk
CD 73 35 25 18
DA 407 189 129 97
% without reintervention
CD 71 69 69 69
DA 77 77 76 74
SE
CD .06 .06 .06 .0
DA .02 .02 .02 .0
CD, Chronic aortic dissection; DA, degenerative aneurysm; TAA, thoracoa
P value determined by Mantel-Cox long-rank univariate analysis.reported a contemporary series of TAA repair of which 27% mere CD. Their overall neurologic deficit rate was 4.3%
ith no difference between CD and DA (3.6% vs 4.5%, P
58).12 A second recent report detailed 660 patients under-
oing TAA repair (21% CD) and again there was no differ-
nce in SCI between CD and DA (2.9% vs 5.5%).11 The
urrent study supports these more contemporary series as
here was no difference in any degree of SCI between the
wo groups.
Historically, we have used the clamp and sew technique
ith EC for spinal cord protection in most TAA repairs,
ith atrial-femoral bypass being reserved for patients in
hom a complex proximal repair is anticipated.9,22 Indeed,
2% of our CD patients were treated with this adjunct.
ther authors have advocated a more liberal approach to
he use of atrial-femoral bypass, with contemporary series
f TAA for CD reporting the use of distal perfusion in 40%
o 80% of patients.11,12 Jacobs et al reported a spinal cord
schemia rate of 4% in a series of 118 patients with types I
nd II TAA treated with distal perfusion.23 We have re-
ently adopted a similar posture of the regular application
f atrial-femoral bypass with monitoring of motor-evoked
otentials for patients with Crawford type I and II aneu-
ysms regardless of etiology with initial favorable results.
The best way to manage patent intercostal arteries,
specially those in the critical region between T8-L1, re-
lated reintervention in patients undergoing TAA strati-
4 5 6 7 8 9 10
16 14 13 9 8 5 2
62 46 30 25 16 10 7
69 69 69 69 69 69 69
72 70 70 70 70 70 70
.06 .06 .06 .06 .06 .06 .06
.03 .04 .04 .04 .04 .04 .04
inal aortic aneurysm.sm-re
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March 2011604 Conrad et alconsistent with our practice) has been an aggressive posture
toward intercostal reconstruction in the T8-L1 seg-
ment.11,12,24,25 Previously, we correlated sacrifice of inter-
costal vessels therein with an increased risk of SCI.14 Yet
this technical operative adjunct has both a weak evidence
base to support its use, and at least in most iterations, is a
largely “blind” maneuver (ie, the surgeon genuinely has no
data as to the necessity of such intercostal reimplant). A
recent large series of TAA repair reported reimplantation of
intercostal arteries in 58% of their cohort (80% of type I and
II repairs) and found the SCI rate was 5.3% in the group
with reimplantation and 13.4% in those that were not
reimplanted (P  .025).11 However, Svensson noted, in a
Fig 2. Kaplan-Meier estimate for survival in patients un
Years 0 1 2 3 4
At risk
CD 73 47 40 37 33
DA 407 288 236 212 175
% survival
CD 93 72 66 64 57
DA 93 78 70 64 55
SE
CD .03 .055 .059 .059 .06
DA .012 .021 .024 .025 .02
P value determined by Mantel-Cox long-rank univariate analysis.
CD, Chronic aortic dissection; DA, degenerative aneurysm; TAA, thoracoa
Table IV. Multivariate predictors of long-term survival
after thoracoabdominal aneurysm repair
Variable Coeff
95% Confidence
interval P value
Spinal cord ischemia 1.47 1.04-20.9 .03
Age 1.04 1.02-1.06 .0001
Hypertension 1.71 1.11-2.64 .02
Preop creatinine 1.37 1.2-1.47 .0001
Chronic obstructive
pulmonary disease
1.37 1.0-1.88 .05prospective study of intercostal preservation, that a majority wf separately reimplanted intercostals occlude within the
rst few hours postoperatively26 and in the current series
which was mostly clamp and sew), intercostal reimplanta-
ion did not decrease SCI. The posture toward intercostal
econstruction has changed over time and a recent review
y Acher et al showed that the addition of intercostal artery
evascularization to their other protective adjuncts reduced
he SCI risk by 75%.27 The presence of atrial-femoral
ypass can complicate intra-operative decision making as it
s common to have vigorous back-bleeding from multiple
airs of intercostal arteries, and reimplantation of all vessels
ould add to the bypass time (and blood turnaround)
hile providing questionable benefit. Because of this,
otor-evoked potentials have been used to predict the
eed for intercostal reconstruction during atrial-femoral
ypass with success.23,28,29 We now monitor motor-
voked potentials in all patients with types I and II TAA
nd most type III. After completing the proximal anas-
omosis, patent intercostal arteries are identified and
ccluded with Pruit catheters. We then proceed to create
he visceral button, checking motor-evoked potentials
requently during this time. If the potentials decrease,
ominate intercostal arteries are reimplanted via an in-
lusion button; if not, they are oversewn.29 This has
esulted in the need for few intercostal reimplantations
ing TAA stratified by indications (CD vs DA).
5 6 7 8 9 10
28 25 22 18 12 9
38 107 81 61 46 28
53 50 47 41 35 32
47 39 33 27 22 16
.063 .065 .065 .066 .066 .069
.027 .027 .027 .026 .026 .024
inal aortic aneurysm.dergo
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Volume 53, Number 3 Conrad et al 605Despite a variety of advances in anesthesia and the
addition of adjunctive techniques, representative large clin-
ical series, including the most recent publications, indicate
that the mortality of elective TAA repair remains essentially
unchanged from Crawford’s initial 8.9%5 with most series
falling in the 7% to 12% range (Table V).8 Indeed, the
results summarized in Table V represent the “best case”
scenario, and the “real world” experience is substantially
worse. Rigberg et al evaluated 1010 patients from the
California Office of Statewide Health Planning and Devel-
opment database and reported a 30-day elective mortality
of 19% that increased to 31% at 1 year.30 There was also a
linear correlation with age at operation so that the 1-year
mortality increased from 18% in patients 60 years old to
40% for patients over 80 years of age.30 Similarly, Cowan et
al reviewed 1542 patients who underwent elective TAA
repair across a spectrum of hospitals throughout the United
States from the National Inpatient Sample. The overall
mortality for TAA repair was a sobering 22.3%, with higher
volume surgeons having better outcomes than low volume
surgeons.31 Chronic dissection was not individually evalu-
ated in these reports based on large databases, but in
multiple single center series, CD was not a predictor of
30-day mortality, nor was there a difference between CD
and DA in the current series.3,11,12
Little information is available regarding the long-term
anatomic follow-up of patients who have undergone TAA
repair. Clouse et al from our own institution reported
anatomic follow-up in 333 patients with an average surveil-
lance interval of 26 months. They reported a 5-year event-
free survival of 71% with chronic dissection not predictive
of need for reintervention.32 In the current report, the
5-year freedom from aneurysm-related reintervention was
69% for CD and 72% for DA, reaffirming that continued
surveillance is necessary in this population. We currently
obtain a baseline computed tomography scan at the first
postoperative visit and then tailor our imaging based on
this result. Patients with normal computed tomography
scans should be re-evaluated in 4 to 5 years while patients
with unaddressed aneurysmal disease should be reim-
aged sooner.
Few studies have looked at the long-term survival of
patients who have undergone TAA repair. Crawford re-
Table V. 30-day mortality results in contemporary series
of thoracoabdominal aneurysm repair
Author (Year) Patients Mortality (%)
Svensson (1993)8 1509 155 (10)
Coselli (2007)42 2286 115 (5)
Safi (2003)7 1004 141 (14)
Grabitz et al (1996)43 260 37 (14)
Estrera et al (2001)18 654 106 (16)
Jacobs (2002)28 184 20 (11)
Conrad (2007)9 455 39 (8)
Total 6352 613 (9.7)ported a 62% 5-year survival in DA patients, which wasignificantly higher than the 50% seen in patients with CD
P  .05). The current series showed no difference in
ong-term survival between the two groups despite the fact
hat the CD patients were an average of 8 years younger
han those with DA at the time of TAA repair. In addition,
he multivariate negative predictors of long-term survival
age, creatinine, hypertension, and pulmonary disease) in
he current series were all predictors of long-term mortality
n Crawford’s first 605 patients.5 The presence of increas-
ng numbers of comorbid conditions can naturally be ex-
ected to increase overall operative risk. Individual series
ave demonstrated increased operative risks in patients with
ntecedent preoperative renal insufficiency.8,17,21,33-37
hese, and the current series reaffirm our posture regarding
he importance of chronic renal insufficiency in clinical
ecision making. Unless there are circumstances where
econstruction of renal artery stenosis (eg, high grade ste-
osis to a single functioning kidney) has the potential to
everse chronic renal insufficiency, we consider a preoper-
tive creatinine of1.8 to be a relative contraindication to
lective TAA repair. Finally, many of the deaths in our series
ere identified through the social security death index
atabase and consequently, the cause of death is unknown.
s a result, we cannot accurately predict the freedom from
neurysm-related death, which is the ultimate goal of TAA
epair regardless of the underlying cause.
ONCLUSIONS
It is clear that advances in operative technique and the
pplication of neuroprotective adjuncts have improved 30-
ay outcomes after TAA repair for CD such that there is no
onger a difference in mortality and paraplegia when com-
ared with DA patients. Evolution of operative strategies,
pecifically protective adjuncts against SCI (even though
hese remain in evolution), has likely played the largest role
n this transition. However, mortality and paraplegia rates
emain significant after TAA, and prevention of aneurysmal
egeneration of the false lumen remains the holy grail of
he management of Type B aortic dissections. Early reports
nvolving the use of stent grafts in the acute phase show
romise38-41 but further study is needed.
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occurrence of paraplegia for type II extent with heart bypass, and
the rates of patch aneurysm. Now we no longer use Crawford
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Dr R. Clement Darling (Albany, NY). Mark, those were
tremendous results, and obviously you’ve shown that you’ve taken
care of one of the most severe complications in thoracoabdominal
aneurysms in paraplegia.
One question I have is, have you used any other adjuncts
besides LA-FA bypass, such as an ax-fem?
And secondly, since you didn’t take it out of the variables, such
as cooling of the renals, it didn’t seem that you showed any benefit,
or do you firmly believe that that’s an important adjunct to
minimizing renal complications in this operation?
Dr Mark F. Conrad. We maintain that renal cooling is an
important adjunct because it minimizes the incidence of postoper-
ative renal failure, which can lead to hemodynamic instability and
delayed paraplegia. So this adjunct is an important component of
the procedure.
We have not used axillofemoral bypasses for distal aortic
perfusion. We essentially transitioned from the clamp-and-sew
method to the atrial-femoral bypass.
Dr Darling. Do you put the patients on atrial-femoral bypass,
or do you have one of the cardiac surgeons do it?
Dr Conrad. Dr Cambria puts the patients on bypass.
Dr Gustavo Oderich (Rochester, Minn). With the advent of
branched stent grafts, the potential advantages of open repair will
be to decrease paraplegia rates by avoiding coverage of the thoracic
aorta and reimplanting intercostals, and to provide a durable result
with low risk of interventions. I noticed that you used the “Craw-
ford patch technique” to reimplant the visceral arteries. We also
used to do that and have a rate of patch aneurysms in 10% to 15%
of patients. To achieve the goals mentioned above, we changed our
strategy from left heart bypass to hypothermic arrest mostly to
provide spinal cord and renal protection. The main reason for is theatches, and instead prefer complete separate revascularization of
ach branch. Can you comment on that, please?
Dr Conrad. When you use circulatory arrest on these patients,
ou are adding a whole new set of complications including addi-
ional bleeding and stroke risk, so this has not been our practice. I
m not familiar with your personal experience with individual
ntercostals grafts, but others have reported poor patency with this
pproach, as many of them have been shown to thrombose on
urveillance imaging. So we have continued with the inclusion
utton/patch technique.
Dr Roy Greenberg (Cleveland, Ohio). Mark, I thought that
as a really good paper and applaud your results. And I think what
ou guys have done is what we’re all struggling with, which is
aking our concurrent treatment groups and comparing them with
istorical controls, which may be recorded in a prospective data-
ase.
You know, our methods of open surgical repair are similar to
ours at the Massachusetts General Hospital, which is to use distal
erfusion, to use in-line mesenteric perfusion if possible. But the
rgument that we most frequently get in with vascular surgeons is
hether or not these should ever be done without perfusion
djuncts. And I was interested in what your thoughts would be
egarding the repair of thoracoabdominal aneurysms, more exten-
ive than type IV. Should such aneurysm repairs ever be considered
ithout perfusion adjuncts?
Dr Conrad. I don’t think so. Certainly, with the clamp-and-
ew methods, we found that in-line mesenteric shunting made a
ig difference in the visceral vessel ischemic time and minimizes
eperfusion injury. In addition, renal cold has significantly de-
reased our postoperative renal failure. So I think that for all type I
o III aneurysms, some type of distal perfusion adjunct should be
sed, and I regularly use renal cold with my type IV aneurysms.
hank you.
